Education
About Us
Working with TipRanks
Follow Us
Cytokinetics (CYTK)
NASDAQ:CYTK
Cytokinetics (CYTK) Ownership Overview
0.82% Insiders
36.77% Mutual Funds
38.51% Other Institutional Investors
22.81% ETFs
1.10% Public Companies and Individual Investors
The ownership structure of Cytokinetics (CYTK) stock is a mix of institutional, retail, and individual investors. Approximately 98.09% of the company’s stock is owned by Institutional Investors, 0.82% is owned by Insiders, and 1.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 02, 2025 | xxxxxxxxxxxxx | $167750 | |
Jun 17, 2025 | xxxxxxxxxxxxx | $65820 | |
Jun 16, 2025 | xxxxxxxxxxxxx | $169000 | |
Jun 05, 2025 | xxxxxxxxxxxxx | $116716 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $274899 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $301425 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $597303 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $642678 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,521,328 | Institution | 9.65% | 396,103,257 | |
| 10,163,070 | Institution | 8.51% | 349,406,347 | |
| 9,831,852 | Institution | 8.23% | 338,019,072 | |
| 4,067,922 | Institution | 3.41% | 139,855,158 | |
| 3,650,492 | Institution | 3.06% | 125,503,915 | |
| 2,010,132 | Institution | 1.68% | 69,108,338 | |
| 1,982,700 | Institution | 1.66% | 68,165,226 | |
| 1,728,229 | Institution | 1.45% | 59,416,513 | |
| 1,662,020 | Institution | 1.39% | 57,140,248 | |
| 1,336,220 | Institution | 1.12% | 45,939,244 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,163,070 | Institution | 8.51% | 349,406,347 | |
| 4,067,922 | Institution | 3.41% | 139,855,158 | |
| 2,010,132 | Institution | 1.68% | 69,108,338 | |
| 1,982,700 | Institution | 1.66% | 68,165,226 | |
| 1,728,229 | Institution | 1.45% | 59,416,513 | |
| 1,662,020 | Institution | 1.39% | 57,140,248 | |
| 1,336,220 | Institution | 1.12% | 45,939,244 | |
| 1,263,059 | Institution | 1.06% | 43,423,968 | |
| 1,168,110 | Institution | 0.98% | 40,159,622 | |
| 1,115,563 | Institution | 0.93% | 38,353,056 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,842,663 | Institution | 3.22% | 132,110,754 | |
| 3,782,066 | Institution | 3.17% | 162,023,707 | |
| 2,962,509 | Institution | 2.48% | 126,913,886 | |
| 2,885,385 | Institution | 2.42% | 99,199,536 | |
| 1,822,668 | Institution | 1.53% | 78,083,097 | |
| 1,649,681 | Institution | 1.38% | 70,672,334 | |
| 1,615,382 | Institution | 1.35% | 53,630,682 | |
| 921,241 | Institution | 0.77% | 31,672,266 | |
| 910,034 | Institution | 0.76% | 31,286,969 | |
| 699,990 | Institution | 0.59% | 24,065,656 |
FAQ
Who Owns Cytokinetics (CYTK)?
According to the latest TipRanks data, approximately 38.51% of the company's stock is held by institutional investors, 0.82% is held by insiders, and 1.10% is held by retail investors.
What percentage of Cytokinetics (CYTK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.51% of Cytokinetics (CYTK) stock is held by institutional investors.
What percentage of Cytokinetics (CYTK) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.10% of Cytokinetics (CYTK) stock is held by retail investors.
Who owns the most shares of Cytokinetics (CYTK)?
Vanguard owns the most shares of Cytokinetics (CYTK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.